These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Administration of recombinant tissue plasminogen activator to a case of cerebral infarction in the setting of painless aortic dissection. Takeuchi S; Takasato Y; Masaoka H; Otani N Neurol India; 2009; 57(6):808-9. PubMed ID: 20139520 [No Abstract] [Full Text] [Related]
46. Alteplase for thrombolysis in acute ischemic stroke. Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507 [No Abstract] [Full Text] [Related]
48. [Thrombolytics and neuroprotective agents in the treatment of the patient with an acute cerebrovascular ischemic accident]. Yepes MS Rev Neurol; 2001 Feb 1-15; 32(3):259-66. PubMed ID: 11310282 [TBL] [Abstract][Full Text] [Related]
49. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats. You YP J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971 [TBL] [Abstract][Full Text] [Related]
50. Effect of nimodipine on final infarct volume after acute ischemic stroke. Fogelholm R; Erilä T; Palomäki H; Murros K; Kaste M Cerebrovasc Dis; 2000; 10(3):189-93. PubMed ID: 10773644 [TBL] [Abstract][Full Text] [Related]
51. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review. Zhang W; Krafft PR; Wang T; Zhang JH; Li L; Tang J Cell Transplant; 2019 Jun; 28(6):657-661. PubMed ID: 30666888 [TBL] [Abstract][Full Text] [Related]